The insurer requests 9th Circ. Claim victory in opioid coverage litigation

By Eli Flesch (September 17, 2021, 7:11 p.m. EDT) – US Specialty Insurance Co. on Friday urged Circuit Ninth to uphold the finding that a California pharmaceutical company was not entitled to coverage for costs incurred in connection with of an investigation of opioid drugs and the company’s marketing practices.

The insurer said an exclusion of goods and products in its policy with San Diego-based drugmaker Sentynl Therapeutics was correctly interpreted to largely exclude coverage for the $ 2.4 million the drug company spent to respond to subpoenas for information on the marketing of levorphanol, one of its prescription opioids. medications.

This is because the policy unambiguously excluded coverage for losses resulting from claims that could …

Stay one step ahead

In the legal profession, information is the key to success. You need to know what’s going on with customers, competitors, practice areas, and industries. Law360 provides the intelligence you need to stay an expert and beat the competition.

  • Access to case data in articles (numbers, filings, courts, nature of prosecution, etc.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, requests, etc.
  • Create personalized alerts for specific articles and topics and more!


Leave A Reply

Your email address will not be published.